Business Description
Aspire Biopharma Holdings Inc. is a Florida-based biopharmaceutical company focused on developing medicines that dissolve under the tongue, allowing them to work faster than traditional pills. Its first product, Instaprin, is a pH-neutral sublingual aspirin designed for rapid relief in heart emergencies and pain management. The company is also working to bring the same delivery approach to a wide range of other products, including melatonin, vitamins, testosterone, semaglutide, anti-nausea and anti-psychotic drugs, seizure medications, and pre-workout supplements. Founded in 2021, Aspire aims to improve how common and critical medications are absorbed by the body.
